Ibere Pharmaceuticals's other current assets is $110K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2022), IBER shows a other current assets of $110K. That compares with $290K in the prior-year period — down 62.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, IBER's other current assets is now $110K (was $290K) — a 62.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ibere Pharmaceuticals is outperforming or lagging.
Tracking IBER's other current assets over time shows whether Ibere Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $110K That compares with $290K in the prior-year period — down 62.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current assets page, Stockcircle has Ibere Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $110K) with ownership activity and broader fundamentals.